Deal Announcement

goetzpartners advised AlzeCure Pharma

Sell-Side Advisory
Healthcare and Life Sciences
Transaction
2018
Icon: flag-SEIcon: flag-SE

goetzpartners advised

goetzpartners was mandated by AlzeCure Pharma for

Strategic Advice

on the IPO of AlzeCure Pharma on the NASDAQ First North

19,400,000 €

Weitere TransaktionenDas könnte Sie auch interessieren...

2019
Icon: flag-DEIcon: flag-CN

goetzpartners advised

goetzpartners was mandated by ITM AG for

Strategic Advice

on a technology license agreement for medical radioisotopes with China Isotope & Radiation Corporation (CIRC)

2019
Icon: flag-DEIcon: flag-DE

goetzpartners advised

goetzpartners was mandated by Vivoryon Therapeutics AG for

Strategic Advice

on the option agreement and equity commitment for its lead compound to MorphoSys AG

15,000,000 €

2007
Icon: flag-ESIcon: flag-ES

goetzpartners advised

McKesson with

Strategic Advice

Alle ansehen